glp-1 medications pros and cons Do The Benefits of Drugs OutWeigh the Negatives? Understanding Weight Loss Medications: GLP-1
Description
June 17, 2024: Wegovy Lawsuit Progresses with First Status Conference Under New Judge Karen Marston On June 10, 2024, the new judge, Karen Marston, held the first status conference in the Wegovy lawsuit since Judge Pratters passing
Ethics declarations Authors relationships and activities MT is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, MA
Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes
indirect evidence through mRNA levels, as well as histologic and most recently direct immunohistochemical evidence, demonstrates that VANs express 42% of the GLP-1R (64, 78)
It was originally developed to treat type 2 diabetes and is now FDA-approved for chronic weight management
